Khabre branded placeholder image

health

First mutation-targeted RNA therapy improves rare ALS case

A man with slowly progressing ALS caused by a rare CHCHD10 mutation showed improved motor-function scores and a biomarker associated with nerve damage returned to the normal reference range one year after receiving a mutation-targeted antisense oligonucleotide treatment.

Khabre branded placeholder image

health

ALS Mouse Study Supports Restoring Multiple TDP-43 Targets

A bioRxiv preprint reports that restoring several TDP-43 cryptic targets, including Unc13a, protected spinal motor neurons in a mouse model of early-stage ALS more effectively than targeting Unc13a alone.